Certara, Inc. (CERT) vs Hemab Therapeutics Holdings, Inc. Common Stock (COAG)

A side-by-side comparison of Certara, Inc. and Hemab Therapeutics Holdings, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Certara, Inc. logo
CERT
Certara, Inc.
$1.46B
$9.36HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
Hemab Therapeutics Holdings, Inc. Common Stock logo
COAG
Hemab Therapeutics Holdings, Inc. Common Stock
$1.34B
$28.70HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT

Total return — CERT vs COAG

growth of $100 · dividends reinvested · last 1y
CERT +64.3% (+64.3%/yr)COAG -10.0% (-10.0%/yr)CERT compounded faster over this window
80100120140160Start $100$164$90
CERT COAG

CERT vs COAG: by the numbers

  • •CERT is the larger company ($1.46B vs $1.34B market cap).
  • •Both run net losses; COAG's is the smaller (0.00% vs -16.75% net margin).

Metrics side by side

Valuation

MetricCERTCOAG
Forward P/E27.48N/A
P/S ratio3.56N/A
P/B ratio1.512.95
EV / EBITDA26.48N/A
FCF yield4.23%N/A

Profitability

MetricCERTCOAG
Gross margin58.33%0.00%
Operating margin1.86%0.00%
Net margin-16.75%0.00%
ROE-7.08%N/A
ROIC0.59%-38.09%

Growth (annualized)

MetricCERTCOAG
Revenue CAGR (5Y)9.31%N/A
FCF CAGR (5Y)8.78%N/A
Total return CAGR (5Y)-21.31%N/A

Go deeper

Full CERT analysisFull COAG analysisInteractive comparison tool

Dig into the metrics

Certara ROEHemab Therapeutics Holdings, Inc. Common Stock ROECertara operating marginHemab Therapeutics Holdings, Inc. Common Stock operating marginCertara revenue growthHemab Therapeutics Holdings, Inc. Common Stock revenue growthCertara free cash flowHemab Therapeutics Holdings, Inc. Common Stock free cash flow

Certara & Hemab Therapeutics Holdings, Inc. Common Stock appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.